Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparative Assessment of Clinical Efficacy of Donepezil Between the Naive Group and the Switching Group

Next Previous
X
Search
Trial Profile

Comparative Assessment of Clinical Efficacy of Donepezil Between the Naive Group and the Switching Group

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jan 2020

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Donepezil (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use

    • Most Recent Events

    • 05 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 27 Jun 2012 Planned End Date changed from 1 Aug 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
    • 23 May 2011 Planned end date changed from 1 Apr 2011 to 1 Aug 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top